Royal Bank of Canada
VMD icon

Royal Bank of Canada’s Viemed Healthcare VMD Stock Holding History

Royal Bank of Canada’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
6,498
+1,781
+38% +$17.6K ﹤0.01% 5578
2026
Q1 		$43K Sell
4,717
-1,108
-19% -$9.22K ﹤0.01% 5568
2025
Q4 		$43K Buy
5,825
+149
+3% +$1.02K ﹤0.01% 5641
2025
Q3 		$38K Sell
5,676
-28,840
-84% -$195K ﹤0.01% 5942
2025
Q2 		$238K Buy
34,516
+3,820
+12% +$25.9K ﹤0.01% 5033
2025
Q1 		$224K Sell
30,696
-166
-0.5% -$1.3K ﹤0.01% 4615
2024
Q4 		$248K Sell
30,862
-72,383
-70% -$628K ﹤0.01% 4636
2024
Q3 		$757K Buy
103,245
+99,587
+2,722% +$711K ﹤0.01% 3761
2024
Q2 		$24K Sell
3,658
-6,582
-64% -$49.6K ﹤0.01% 6002
2024
Q1 		$96K Sell
10,240
-8,380
-45% -$71.8K ﹤0.01% 5216
2023
Q4 		$146K Sell
18,620
-98,262
-84% -$713K ﹤0.01% 5358
2023
Q3 		$788K Buy
116,882
+740
+0.6% +$6.06K ﹤0.01% 3644
2023
Q2 		$1.14M Sell
116,142
-5,347
-4% -$54.3K ﹤0.01% 3259
2023
Q1 		$1.17M Sell
121,489
-31,634
-21% -$276K ﹤0.01% 3229
2022
Q4 		$1.16M Sell
153,123
-6,012
-4% -$40.7K ﹤0.01% 3378
2022
Q3 		$955K Sell
159,135
-7,240
-4% -$46.5K ﹤0.01% 3498
2022
Q2 		$895K Sell
166,375
-2,125
-1% -$11.5K ﹤0.01% 3607
2022
Q1 		$839K Buy
168,500
+4,649
+3% +$21.6K ﹤0.01% 3814
2021
Q4 		$856K Buy
163,851
+52,362
+47% +$292K ﹤0.01% 3974
2021
Q3 		$618K Sell
111,489
-775
-0.7% -$5.04K ﹤0.01% 4178
2021
Q2 		$804K Buy
112,264
+986
+0.9% +$8.54K ﹤0.01% 3851
2021
Q1 		$1.13M Buy
111,278
+45,286
+69% +$426K ﹤0.01% 3467
2020
Q4 		$513K Sell
65,992
-7,474
-10% -$65.8K ﹤0.01% 4113
2020
Q3 		$636K Sell
73,466
-8,059
-10% -$81.3K ﹤0.01% 3656
2020
Q2 		$783K Buy
81,525
+58,891
+260% +$458K ﹤0.01% 3390
2020
Q1 		$108K Sell
22,634
-18,920
-46% -$93.8K ﹤0.01% 4732
2019
Q4 		$257K Buy
41,554
+6,127
+17% +$42.5K ﹤0.01% 4461
2019
Q3 		$245K Buy
+35,427
New +$236K ﹤0.01% 4321

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Royal Bank of Canada's VMD Position: Q2 2026 in Review

Royal Bank of Canada increased its Viemed Healthcare (VMD) stake by 38% in Q2 2026, buying an estimated $17.6K and bringing the position to 6,498 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #5578.

Royal Bank of Canada first reported a position in VMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.17M in Q1 2023. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Royal Bank of Canada held 6,498 shares of Viemed Healthcare worth $74K as of Q2 2026.
  • Royal Bank of Canada bought 1,781 Viemed Healthcare shares in Q2 2026, an estimated $17.6K.
  • Viemed Healthcare made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5578 holding.
  • Royal Bank of Canada first reported a position in Viemed Healthcare in Q3 2019 and has held it in 28 quarters since.
  • Royal Bank of Canada's Viemed Healthcare position peaked at $1.17M in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.